BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22017213)

  • 1. Warfarin management after discharge from hospital: a qualitative analysis.
    Stafford L; van Tienen EC; Peterson GM; Bereznicki LR; Jackson SL; Bajorek BV; Mullan JR; DeBoos IM
    J Clin Pharm Ther; 2012 Aug; 37(4):410-4. PubMed ID: 22017213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service.
    Stafford L; Peterson GM; Bereznicki LR; Jackson SL; van Tienen EC; Angley MT; Bajorek BV; McLachlan AJ; Mullan JR; Misan GM; Gaetani L
    Ann Pharmacother; 2011 Mar; 45(3):325-34. PubMed ID: 21386021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of pharmacist-delivered warfarin education in the home.
    Stafford L; van Tienen EC; Bereznicki LR; Peterson GM
    Int J Pharm Pract; 2012 Dec; 20(6):384-9. PubMed ID: 23134097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General surgical patients' perspectives of the adequacy and appropriateness of discharge planning to facilitate health decision-making at home.
    McMurray A; Johnson P; Wallis M; Patterson E; Griffiths S
    J Clin Nurs; 2007 Sep; 16(9):1602-9. PubMed ID: 17727581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance improvement in managed long-term care: improving warfarin medication management.
    Desmond D; Kogan P; Underwood S; Brobbey E; Luib P
    Home Healthc Nurse; 2009 Mar; 27(3):150-9. PubMed ID: 19279480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discharge teaching about warfarin: patient retention of knowledge.
    Cook-Campbell J; Sefton M
    Home Healthc Nurse; 2010 Jun; 28(6):366-74. PubMed ID: 20539139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.
    Stafford L; Peterson GM; Bereznicki LR; Jackson SL
    BMC Health Serv Res; 2011 Jan; 11():16. PubMed ID: 21261998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing anticoagulation knowledge in patients new to warfarin therapy.
    Winans AR; Rudd KM; Triller D
    Ann Pharmacother; 2010; 44(7-8):1152-7. PubMed ID: 20571105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
    Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML
    Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation.
    Jackson SL; Peterson GM; Vial JH; Jupe DM
    J Intern Med; 2004 Aug; 256(2):137-44. PubMed ID: 15257726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty.
    Schuringa P; Yen D
    Can J Surg; 1999 Oct; 42(5):360-2. PubMed ID: 10526520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: description of successful outcomes.
    Jackson SL; Peterson GM; House M; Bartlett T
    Aust J Rural Health; 2004 Oct; 12(5):197-200. PubMed ID: 15588262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the continuity of care between general practitioners and public hospitals.
    Balla JI; Jamieson WE
    Med J Aust; 1994 Dec 5-19; 161(11-12):656-9. PubMed ID: 7830630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitions of care in patients receiving oral anticoagulants: general principles, procedures, and impact of new oral anticoagulants.
    Johnson MP
    J Cardiovasc Nurs; 2013; 28(1):54-65. PubMed ID: 23222178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.